BridgeBio Pharma, Inc is a biotechnology business based in the US. BridgeBio Pharma shares (BBIO) are listed on the NASDAQ and all prices are listed in US Dollars. BridgeBio Pharma employs 385 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in BridgeBio Pharma
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BBIO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
BridgeBio Pharma stock price (NASDAQ: BBIO)Use our graph to track the performance of BBIO stocks over time.
BridgeBio Pharma shares at a glance
|Latest market close||$59.20|
|52-week range||$26.17 - $73.50|
|50-day moving average||$61.56|
|200-day moving average||$61.28|
|Wall St. target price||$81.63|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-10.90|
Buy BridgeBio Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy BridgeBio Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BridgeBio Pharma price performance over time
|1 week (2021-07-13)||N/A|
|1 month (2021-06-24)||-0.50%|
|3 months (2021-04-20)||N/A|
|6 months (2021-01-20)||N/A|
|1 year (2020-07-20)||N/A|
|2 years (2019-07-20)||N/A|
|3 years (2018-07-20)||N/A|
|5 years (2016-07-20)||N/A|
BridgeBio Pharma financials
|Revenue TTM||$8.7 million|
|Gross profit TTM||$8.2 million|
|Return on assets TTM||-32.37%|
|Return on equity TTM||-1789.67%|
|Market capitalisation||$9.2 billion|
TTM: trailing 12 months
Shorting BridgeBio Pharma shares
There are currently 11.1 million BridgeBio Pharma shares held short by investors – that's known as BridgeBio Pharma's "short interest". This figure is 6.4% up from 10.5 million last month.
There are a few different ways that this level of interest in shorting BridgeBio Pharma shares can be evaluated.
BridgeBio Pharma's "short interest ratio" (SIR)
BridgeBio Pharma's "short interest ratio" (SIR) is the quantity of BridgeBio Pharma shares currently shorted divided by the average quantity of BridgeBio Pharma shares traded daily (recently around 1.2 million). BridgeBio Pharma's SIR currently stands at 9.62. In other words for every 100,000 BridgeBio Pharma shares traded daily on the market, roughly 9620 shares are currently held short.
However BridgeBio Pharma's short interest can also be evaluated against the total number of BridgeBio Pharma shares, or, against the total number of tradable BridgeBio Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case BridgeBio Pharma's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 BridgeBio Pharma shares in existence, roughly 70 shares are currently held short) or 0.1546% of the tradable shares (for every 100,000 tradable BridgeBio Pharma shares, roughly 155 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against BridgeBio Pharma.
Find out more about how you can short BridgeBio Pharma stock.
BridgeBio Pharma share dividends
We're not expecting BridgeBio Pharma to pay a dividend over the next 12 months.
BridgeBio Pharma share price volatility
Over the last 12 months, BridgeBio Pharma's shares have ranged in value from as little as $26.17 up to $73.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BridgeBio Pharma's is 0.7649. This would suggest that BridgeBio Pharma's shares are less volatile than average (for this exchange).
BridgeBio Pharma overview
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include BBP-265, a small molecule stabilizer of transthyretin, or TTR, that is in an ongoing Phase 3 clinical trial for the treatment of TTR amyloidosis-cardiomyopathy, or ATTR-CM; BBP-831, a small molecule selective FGFR1-3 inhibitor which is an ongoing Phase 2 clinical trial for the treatment of achondroplasia in pediatric patients; an AAV5 gene transfer product candidate for the treatment of congenital adrenal hyperplasia, or CAH, driven by 21-hydroxylase deficiency, or 21OHD; and Encaleret, a small molecule antagonist of the calcium sensing receptor, or CaSR, an ongoing phase 2 proof-of-concept clinical trial for Autosomal Dominant Hypocalcemia Type 1, or ADH1. The company also engages in developing products for Mendelian, genetic dermatology, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license and collaboration agreements with the Leland Stanford Junior University; The Regents of the University of California; Leidos Biomedical Research, Inc.
Stocks similar to BridgeBio Pharma
BridgeBio Pharma in the news
First Week of BBIO September 17th Options Trading
First Week of BBIO September 17th Options Trading
Hedge Funds Are Crazy About BridgeBio Pharma, Inc. (BBIO)
Frequently asked questionsWhat percentage of BridgeBio Pharma is owned by insiders or institutions?
Currently 7.494% of BridgeBio Pharma shares are held by insiders and 95.617% by institutions. How many people work for BridgeBio Pharma?
Latest data suggests 385 work at BridgeBio Pharma. When does the fiscal year end for BridgeBio Pharma?
BridgeBio Pharma's fiscal year ends in December. Where is BridgeBio Pharma based?
BridgeBio Pharma's address is: 421 Kipling Street, Palo Alto, CA, United States, 94301 What is BridgeBio Pharma's ISIN number?
BridgeBio Pharma's international securities identification number is: US10806X1028 What is BridgeBio Pharma's CUSIP number?
BridgeBio Pharma's Committee on Uniform Securities Identification Procedures number is: 10806X102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert